We performed analyses including TIMP-1 both as a continuous log-transformed variable and as a dichotomized variable with patients divided into two groups of high and low tumor tissue TIMP-1 levels, respectively, by the median TIMP-1 concentration of the total patient group. This evidence concerns the gene TIMP1 and neoplasm.